Caris Life Sciences vs Cue Biopharma, .
Caris Life Sciences vs Cue Biopharma, ., compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Caris Life Sciences is on 59/100 and Cue Biopharma, . on 62/100.
Where each one leads
Caris Life Sciences
- agent readiness: 47/100 against 42/100
- domain rating: 63/100 against 34/100
- headcount: 1,659 against 38
- funding raised: $700M against $10.0M
- LinkedIn following: 77,698 against 5,297
Cue Biopharma, .
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Caris Life Sciences | Cue Biopharma, . |
|---|---|---|
| What it is | Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling. | Developing engineered biologics to harness the immune system for disease treatment. |
| Category | Biotech, MedTech, HealthTech, Genomics | Biotech, Drug Discovery, Immunotherapy, Therapeutics |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Biotech |
| Founded | 2008 | 2017 |
| Headquarters | Irving, United States | Boston, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Caris Life Sciences | Cue Biopharma, . |
|---|---|---|
| Employees | 1,659 | 38 |
| Total funding | $700M | $10.0M |
| Latest round | Series D | Seed |
| Valuation | $7.8B | Not published |
| LinkedIn followers | 77,698 | 5,297 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Caris Life Sciences | Cue Biopharma, . |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 59/100 | 62/100 |
| Traction | 60/100 | Not published |
| Team | Not published | 60/100 |
| Search visibility | 22/100 | 67/100 |
| Quality | 78/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | D (47/100) | D (42/100) |
| Domain ratingLink authority, 0-100 | 63/100 | 34/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Caris Life Sciences | Cue Biopharma, . |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Not detected | Tailwind CSS |
| Analytics | Google Tag Manager | Google Analytics 4 |
Caris Life Sciences vs Cue Biopharma, .: common questions
Which is better, Caris Life Sciences or Cue Biopharma, .?
On our 0-100 score Cue Biopharma, . rates higher (62/100 against 59/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Caris Life Sciences and Cue Biopharma, . compare on the numbers?
Caris Life Sciences leads on agent readiness (47/100 against 42/100), domain rating (63/100 against 34/100), headcount (1,659 against 38), funding raised ($700M against $10.0M), LinkedIn following (77,698 against 5,297).
Read the full Caris Life Sciences review and pricing or the Cue Biopharma, . review and pricing. You can also browse other Caris Life Sciences alternatives we track.